The science behind Flibanserin
If you have been following this site you are well aware that the first drug marketed towards treating effects of HSDD or FSD may well be on it's way to daily commercials under the guise of Girosa or Ectris very soon. So what's this Flibanserin made from and where did it come from you may ask. Let's take a look behind the scenes to get the break down on this new drug
Code name BIMT-17
That's the code name for the drug developed by Boehringer Ingelheim. Boehringer orinally developed the drug as an anti-depressent but soon realized that while it didn't perform well in that function there was a curious side effect recognized during the clinical trials.
Flibanserin is a 5-HT receptor full agonist, D4 receptor partial agonist, and a 5-HT receptor antagonist. What does this mean? To simplify Girosa alters chemical reactions in the brain that are understood to activate sexual desire in women. That means, yes, you're right. It works in women's minds to increase the ability to get sexually excited. Unlike Viagra the men's magic pill which works it's miracle by increasing blood flow to the penis Flibanserin works it's magic in the brain.
Boehringer Ingelheim?
There have been several patents in the following names:
- Carlo Bombarda
- Enrica Dubini
- Anoine Ezhaya
- Franco Borsini
- Kenneth Robert Evans
Dating back as far as 2002 all surrounding the use of Flibanserin as a method of treating hypoactive sexual desire disorder. That means this has been a long time in the making. In fact, Boehringer has had Ectris in clinical trials for almost 4 years now. Tests results are looking pretty good analysts say so the hard work and wait may be worth the while. Especially since it's estimated that over 35 percent of all women suffer from the side effects of sexual disorders.
Watch this recent news report on Flibanserin and see what analyst have been talking about
And as always be sure to check in often as FeminineReview is the premier location to find the latest news on female libido improvement and FDA approved drugs related to FSD and HSDD. As you may know Flibanserin is no longer on the market but LibiGel is next to fight the good fight with the FDA for approvals. Let's see what happens.